A detailed history of Intrua Financial, LLC transactions in Dexcom Inc stock. As of the latest transaction made, Intrua Financial, LLC holds 2,440 shares of DXCM stock, worth $195,785. This represents 0.06% of its overall portfolio holdings.

Number of Shares
2,440
Previous 2,440 -0.0%
Holding current value
$195,785
Previous $276,000 2.54%
% of portfolio
0.06%
Previous 0.06%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Jan 20, 2023

BUY
$84.98 - $122.67 $207,351 - $299,314
2,440 New
2,440 $0
Q2 2022

Aug 12, 2022

SELL
$67.99 - $132.89 $45,757 - $89,434
-673 Closed
0 $0
Q1 2022

May 11, 2022

BUY
$94.08 - $130.2 $282 - $390
3 Added 0.45%
673 $344,000
Q4 2020

Feb 03, 2021

BUY
$78.0 - $104.5 $52,260 - $70,015
670 New
670 $248,000

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $31B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Intrua Financial, LLC Portfolio

Follow Intrua Financial, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Intrua Financial, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Intrua Financial, LLC with notifications on news.